Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

@article{McClune2010EffectOA,
  title={Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.},
  author={Brian L McClune and Daniel J. Weisdorf and Tanya L Pedersen and Gisela Tunes da Silva and Martin S. Tallman and Jorge Sierra and John F. DiPersio and Armand Keating and Robert Peter Gale and Biju George and Vikas Gupta and T. B. Hahn and Luis M. Isola and Madan H. Jagasia and Hillard Lazarus and David C Marks and Richard T Maziarz and Edmund K Waller and Chris Bredeson and Sergio Giralt},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2010},
  volume={28 11},
  pages={1878-87}
}
PURPOSE Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) primarily afflict older individuals. Hematopoietic cell transplantation (HCT) is generally not offered because of concerns of excess morbidity and mortality. Reduced-intensity conditioning (RIC) regimens allow increased use of allogeneic HCT for older patients. To define prognostic factors impacting long-term outcomes of RIC regimens in patients older than age 40 years with AML in first complete remission or MDS and to… CONTINUE READING
Highly Influential
This paper has highly influenced 13 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
138 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 138 extracted citations

Similar Papers

Loading similar papers…